10 completed, 2 recruiting, 2 terminated. 14 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 14 | Completed 10, Recruiting 2, Terminated 2 |
Follow Refractory Multiple Myeloma: new trials by email Literature Review of Refractory Multiple Myeloma trials Research Report on Refractory Multiple Myeloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma Biospecimen Collection, Cognitive Intervention, Electronic Health Record Review - Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Multiple Myeloma | Not applicable | Recruiting | Ohio State University Comprehensive Cancer Center | 90 | 2026-04-28 | 2026-05-27 |
| Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma Accelerometry, Aerobic Exercise, Biospecimen Collection - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Not applicable | Terminated | Mayo Clinic | 12 | 2025-08-18 | 2026-07-01 |
| Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab Digital Health Coaching Program, Fitbit - Multiple Myeloma, Refractory Multiple Myeloma | Not applicable | Recruiting | Pack Health | 50 | 2022-06-17 | 2024-12-11 |
| High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia Biospecimen Collection, High Throughput Screening, Laboratory Biomarker Analysis - Plasma Cell Leukemia, Recurrent Multiple Myeloma | Not applicable | Completed | University of Washington | 40 | 2018-02-14 | 2026-09-16 |
| Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients cryotherapy, questionnaire administration, pharmacological study - Refractory Multiple Myeloma, Stage I Multiple Myeloma | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 148 | 2012-04-01 | 2017-06-27 |
| Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma bortezomib, filgrastim, autologous hematopoietic stem cell transplantation - Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia | Not applicable | Completed | Barbara Ann Karmanos Cancer Institute | 23 | 2011-07-01 | 2021-05-10 |
| Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer palifermin, flow cytometry, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Completed | Martin, Paul | 6 | 2010-09-01 | 2014-04-02 |
| Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies plerixafor, filgrastim, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Terminated | Fred Hutchinson Cancer Center | 1 | 2010-06-01 | 2017-06-28 |
| Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer massage therapy, questionnaire administration, quality-of-life assessment - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia | Not applicable | Completed | Wake Forest University Health Sciences | 80 | 2010-04-01 | 2018-07-02 |
| Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders fludarabine phosphate, melphalan, total-body irradiation - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Not applicable | Completed | Roswell Park Cancer Institute | 62 | 2009-01-14 | 2019-11-13 |
| High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors etoposide, cyclophosphamide, carmustine - Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Not applicable | Completed | Roswell Park Cancer Institute | 174 | 2006-06-29 | 2021-04-22 |
| Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies fludarabine phosphate, total-body irradiation, peripheral blood stem cell transplantation - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia | Not applicable | Completed | Fred Hutchinson Cancer Center | 160 | 2000-12-01 | 2020-01-21 |
| Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer fludarabine phosphate, total-body irradiation, nonmyeloablative allogeneic hematopoietic stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Completed | Fred Hutchinson Cancer Center | 55 | 1999-11-01 | 2019-09-10 |
| Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma chemotherapy, total-body irradiation, peripheral blood stem cell transplantation - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Not applicable | Completed | Fred Hutchinson Cancer Center | 63 | 1997-09-01 | 2019-12-27 |
Multiple Myeloma (14) · Leukemia, Lymphocytic, Chronic, B-Cell (9) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (9) · Burkitt Lymphoma (8) · Lymphoma, B-Cell, Marginal Zone (8) · Lymphoma, Follicular (8) · Lymphoma, Large B-Cell, Diffuse (8) · Lymphoma, Non-Hodgkin (8) · Lymphoma, T-Cell, Cutaneous (8) · Leukemia, Hairy Cell (7) · Lymphoma, Large-Cell, Immunoblastic (7) · Lymphoma, Mantle-Cell (7) · Mycosis Fungoides (7) · Sezary Syndrome (7) · Congenital Abnormalities (6)
Blood Protein Disorders (14) · Cardiovascular Diseases (14) · Hematologic Diseases (14) · Hemic and Lymphatic Diseases (14) · Hemorrhagic Disorders (14) · Hemostatic Disorders (14) · Immune System Diseases (14) · Immunoproliferative Disorders (14) · Lymphoproliferative Disorders (14) · Neoplasms (14) · Neoplasms by Histologic Type (14) · Paraproteinemias (14) · Vascular Diseases (14) · Neoplasms, Plasma Cell (13) · Leukemia (10)
Whole-Body Irradiation (5) · Peripheral Blood Stem Cell Transplantation (4) · Cyclosporine (3) · Mycophenolic Acid (3) · fludarabine phosphate (3) · Filgrastim (2) · Granulocyte Colony-Stimulating Factor (2) · Melphalan (2) · Specimen Handling (2) · Accelerometry (1) · Antilymphocyte Serum (1) · Bortezomib (1) · Busulfan (1) · Carboplatin (1) · Carmustine (1)
Fred Hutchinson Cancer Center (4) · Ohio State University Comprehensive Cancer Center (2) · Roswell Park Cancer Institute (2) · Barbara Ann Karmanos Cancer Institute (1) · Martin, Paul (1) · Mayo Clinic (1) · Pack Health (1) · University of Washington (1) · Wake Forest University Health Sciences (1)
United States (14) · Germany (3) · Italy (2)
David Maloney (2) · Ashley E Rosko, MD (1) · Brenda Sandmaier (1) · Craig Hofmeister, MD (1) · Danai Dima, MD (1) · Diane K. Ehlers, PhD (1) · Divaya Bhutani, M.D. (1) · George Chen (1) · Janet Tooze, PhD (1) · Melody R Becnel, MD (1) · Nadine H. Abdallah, MD (1) · Paul Martin (1) · Philip McCarthy (1) · Rahul Banerjee, MD (1) · William Bensinger (1)
P30CA015704 (3), P01CA018029 (1), P30CA016056 (1), P30CA022453 (1)